Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and atherosclerosis: possible implications for therapy

H Bult1

  • 1Department of Medicine, University of Antwerp (UIA), Wilrijk, Belgium. bult@uia.ua.ac.be

Molecular Medicine Today
|December 1, 1996
PubMed
Summary

High cholesterol and atherosclerosis impair nitric oxide (NO) regulation of blood vessel tone, leading to vasospasm and pain. Endothelial dysfunction, involving NO, is an early factor in disease progression with potential therapeutic relevance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells.

British journal of pharmacology·2009
Same author

Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells.

British journal of pharmacology·2008
Same author

Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.

British journal of pharmacology·2007
Same author

Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways.

Annals of the New York Academy of Sciences·2007
Same author

Altered Ca2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions.

Cell calcium·2006
Same author

Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease.

Cardiovascular & hematological disorders drug targets·2006

Area of Science:

  • Cardiovascular Science
  • Endothelial Biology
  • Lipid Metabolism

Background:

  • Atherosclerosis and hypercholesterolemia disrupt endothelium-dependent vascular tone regulation.
  • This dysfunction is mediated by impaired nitric oxide (NO) bioavailability.
  • Endothelial dysfunction is an early event in atherogenesis, affecting even microcirculation.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) in endothelial dysfunction.
  • To explore the impact of NO on vascular tone regulation in atherosclerosis.
  • To assess the potential of NO modulation in managing atherosclerotic disease progression.

Main Methods:

  • Analysis of endothelial function markers.
  • Assessment of vascular tone regulation mechanisms.

Related Experiment Videos

  • Evaluation of nitric oxide (NO) bioavailability in preclinical models.

    • Main Results:

    • Endothelial dysfunction, linked to impaired NO signaling, is a key feature of atherosclerosis.
    • Reduced NO bioavailability contributes to vasospasm and ischemic events.
    • Evidence suggests NO plays a role in modulating atherosclerotic disease progression.

    Conclusions:

    • Nitric oxide (NO) is crucial for maintaining vascular tone and endothelial health.
    • Dysfunctional NO regulation is central to atherogenesis and its clinical manifestations.
    • Targeting NO pathways may offer novel therapeutic strategies for atherosclerosis.